Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Fresh From The White House, J&J's Gorsky Talks Policy, Drug Pricing

Executive Summary

CEO pledges transparency and responsible pricing of J&J drugs during the company’s earnings call, while outlining its goals for US health care and tax reform. Fourth quarter performance was unspectacular, although J&J's oncology and immunology portfolios showed sales growth.

Advertisement

Related Content

Earnings Winners and Losers: BSX, EW, ABT, JNJ, SYK, ZBH
Stockwatch: Mistaken Acquisitions Dim Earnings Season
J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value
J&J Promotes Preventive Care, Wellness In US Health Debate
J&J's Actelion Courtship Seen Unaffected By Macitentan MAESTRO Failure
J.P. Morgan Notebook Day 2: Bristol Humbled By Competition, Sanofi’s Sarilumab Ready For Review, Justifying Spinraza’s Price And More
Rx For Industry: Key Provisions Of The 21st Century Cures Act
Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform
Pharma Is Ready And Waiting For A Tax Holiday Under Trump
Janssen Expanding Its Disease Interception Efforts

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC098099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel